The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 02, 2018
Filed:
Jan. 15, 2013
Applicant:
Institut National DE LA Santa ET DE LA Recherche Medicale (Inserm), Paris, FR;
Inventors:
Michele Aguera, Caluire, FR;
Jean-Christophe Antoine, Chalain le Comtal, FR;
Marie-Francoise Belin, Lyons, FR;
Jerome Honnorat, Bron, FR;
Veronique Rogemond, Lyons, FR;
Assignee:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/705 (2006.01); C07K 14/47 (2006.01); C07K 14/435 (2006.01); C07K 16/18 (2006.01); G01N 33/68 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/47 (2013.01); C07K 14/435 (2013.01); C07K 14/4713 (2013.01); C07K 14/4748 (2013.01); C07K 14/705 (2013.01); C07K 16/18 (2013.01); G01N 33/6854 (2013.01); A61K 38/00 (2013.01);
Abstract
A purified polypeptide, designated ULIP6, comprising the amino acid sequence SEQ ID No. 2 or an epitopic fragment of said polypeptide, comprising the sequence SEQ ID No. 4, is provided along with its nucleic acid sequences. In addition, antibodies to the polypeptide and methods of diagnosing paraneoplastic neurological syndromes and/or for the early diagnosis of the formation of cancerous tumors are also provided.